-
Something wrong with this record ?
Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3
D. Damgaard, M. Bawadekar, L. Senolt, A. Stensballe, MA. Shelef, CH. Nielsen,
Language English Country United States
Document type Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
NLK
Directory of Open Access Journals
from 2006
Free Medical Journals
from 2006
Public Library of Science (PLoS)
from 2006
PubMed Central
from 2006
Europe PubMed Central
from 2006
ProQuest Central
from 2006-12-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-01-01
Open Access Digital Library
from 2006-10-01
Medline Complete (EBSCOhost)
from 2008-01-01
Nursing & Allied Health Database (ProQuest)
from 2006-12-01
Health & Medicine (ProQuest)
from 2006-12-01
Public Health Database (ProQuest)
from 2006-12-01
ROAD: Directory of Open Access Scholarly Resources
from 2006
- MeSH
- Citrullination MeSH
- Fibrinogen immunology MeSH
- Phosphopyruvate Hydratase immunology MeSH
- Histones immunology MeSH
- Hydrogen-Ion Concentration MeSH
- Humans MeSH
- Protein-Arginine Deiminases metabolism MeSH
- Anti-Citrullinated Protein Antibodies metabolism MeSH
- Recombinant Proteins metabolism MeSH
- Arthritis, Rheumatoid enzymology immunology MeSH
- Serum Albumin immunology MeSH
- Synovial Fluid MeSH
- In Vitro Techniques MeSH
- Calcium metabolism MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Research Support, N.I.H., Extramural MeSH
OBJECTIVE: Peptidylarginine deiminase 2 (PAD2) and PAD4 are expressed in the synovium of rheumatoid arthritis (RA) patients and catalyze citrullination of arginine residues in proteins targeted by anti-citrullinated protein antibodies (ACPAs). Little is known about the relative importance of PAD2 and PAD4 in generating citrullinated self-antigens. Here we investigate the ability of PAD2 and PAD4 to generate citrullinated targets for ACPAs in four human proteins. METHODS: Synovial fluid (SF) and plasma were collected from 42 RA patients. Human fibrinogen, human alpha-enolase (ENO1), human histone H3, and human serum albumin (HSA) were citrullinated in vitro by PAD2 or PAD4. The total degree of citrullination was determined using the anti-modified citrulline approach. Antibody binding to native and citrullinated proteins was measured by ELISA. RESULTS: ACPAs within pooled SF from multiple RA patients reacted equally well with, and cross-reacted with, PAD2- and PAD4-citrullinated fibrinogen. ACPAs from most individual patient SF and plasma samples bound equally well to PAD2- and PAD4-citrullinated fibrinogen or ENO1. When histone H3 was used as target, PAD4 was generally superior in generating epitopes recognized by ACPAs. No binding to citrullinated HSA was observed. CONCLUSION: In most patients, PAD2 and PAD4 are equally efficient in generating citrullinated target sites for ACPAs in fibrinogen and ENO1. The binding of autoantibodies to histone H3 was generally higher after citrullination with PAD4 than with PAD2. Citrullinated HSA is not a target for ACPAs.
Department of Health Science and Technology Aalborg University Aalborg Denmark
Department of Medicine University of Wisconsin Madison Wisconsin United States of America
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19012422
- 003
- CZ-PrNML
- 005
- 20190409160400.0
- 007
- ta
- 008
- 190405s2018 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1371/journal.pone.0203214 $2 doi
- 035 __
- $a (PubMed)30161253
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Damgaard, Dres $u Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Section for Periodontology, Microbiology and Community Dentistry, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- 245 10
- $a Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3 / $c D. Damgaard, M. Bawadekar, L. Senolt, A. Stensballe, MA. Shelef, CH. Nielsen,
- 520 9_
- $a OBJECTIVE: Peptidylarginine deiminase 2 (PAD2) and PAD4 are expressed in the synovium of rheumatoid arthritis (RA) patients and catalyze citrullination of arginine residues in proteins targeted by anti-citrullinated protein antibodies (ACPAs). Little is known about the relative importance of PAD2 and PAD4 in generating citrullinated self-antigens. Here we investigate the ability of PAD2 and PAD4 to generate citrullinated targets for ACPAs in four human proteins. METHODS: Synovial fluid (SF) and plasma were collected from 42 RA patients. Human fibrinogen, human alpha-enolase (ENO1), human histone H3, and human serum albumin (HSA) were citrullinated in vitro by PAD2 or PAD4. The total degree of citrullination was determined using the anti-modified citrulline approach. Antibody binding to native and citrullinated proteins was measured by ELISA. RESULTS: ACPAs within pooled SF from multiple RA patients reacted equally well with, and cross-reacted with, PAD2- and PAD4-citrullinated fibrinogen. ACPAs from most individual patient SF and plasma samples bound equally well to PAD2- and PAD4-citrullinated fibrinogen or ENO1. When histone H3 was used as target, PAD4 was generally superior in generating epitopes recognized by ACPAs. No binding to citrullinated HSA was observed. CONCLUSION: In most patients, PAD2 and PAD4 are equally efficient in generating citrullinated target sites for ACPAs in fibrinogen and ENO1. The binding of autoantibodies to histone H3 was generally higher after citrullination with PAD4 than with PAD2. Citrullinated HSA is not a target for ACPAs.
- 650 _2
- $a protilátky proti citrulinovaným peptidům $x metabolismus $7 D000075422
- 650 _2
- $a revmatoidní artritida $x enzymologie $x imunologie $7 D001172
- 650 _2
- $a vápník $x metabolismus $7 D002118
- 650 _2
- $a citrulinace $7 D000076302
- 650 _2
- $a fibrinogen $x imunologie $7 D005340
- 650 _2
- $a histony $x imunologie $7 D006657
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a koncentrace vodíkových iontů $7 D006863
- 650 _2
- $a techniky in vitro $7 D066298
- 650 _2
- $a fosfopyruváthydratasa $x imunologie $7 D010751
- 650 _2
- $a peptidylarginindeiminasy $x metabolismus $7 D000076342
- 650 _2
- $a rekombinantní proteiny $x metabolismus $7 D011994
- 650 _2
- $a sérový albumin $x imunologie $7 D012709
- 650 _2
- $a synoviální tekutina $7 D013582
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a Research Support, N.I.H., Extramural $7 D052061
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Bawadekar, Mandar $u Department of Medicine, University of Wisconsin, Madison, Wisconsin, United States of America.
- 700 1_
- $a Senolt, Ladislav $u Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
- 700 1_
- $a Stensballe, Allan $u Department of Health Science and Technology, Aalborg University, Aalborg, Denmark.
- 700 1_
- $a Shelef, Miriam A $u Department of Medicine, University of Wisconsin, Madison, Wisconsin, United States of America. William S. Middleton Memorial Veterans Hospital, Madison, Wisconsin, United States of America.
- 700 1_
- $a Nielsen, Claus H $u Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. Section for Periodontology, Microbiology and Community Dentistry, Department of Odontology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- 773 0_
- $w MED00180950 $t PloS one $x 1932-6203 $g Roč. 13, č. 8 (2018), s. e0203214
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30161253 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20190405 $b ABA008
- 991 __
- $a 20190409160415 $b ABA008
- 999 __
- $a ok $b bmc $g 1391732 $s 1050727
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 13 $c 8 $d e0203214 $e 20180830 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
- LZP __
- $a Pubmed-20190405